Swipe om te navigeren naar een ander artikel
In many surveys, inflammatory bowel disease (IBD) has been shown to have a negative impact on health-related quality of life (HRQoL), especially when the disease is active. The purpose of this study was to compare a disease-specific HRQoL tool (Inflammatory Bowel Disease Questionnaire, IBDQ) and a generic HRQoL tool (15D) in a large cohort of IBD patients, to assess the ability of the 15D to detect differences in HRQoL between disease states and to compare the HRQoL of IBD patients with that of the general population.
The study population comprised 2,931 IBD patients over 18 picked from a national Social Insurance Institute register and from a patient organization register. The 15D data for the general population came from the National Health 2000 Health Examination Survey.
For patients with IBD, the 15D tool was feasible and had good discriminatory power. The total 15D score was significantly higher among patients with less active disease estimated by frequency of IBD symptoms and was strongly correlated with total IBDQ score. The general population scored significantly higher than did the study subjects on most of the 15D dimensions.
The 15D was a fast and easy-to-apply method for the examination of HRQoL in IBD patients. In addition to HRQoL studies it could be used in everyday practice as well. Patients with IBD have worse HRQoL than do gender- and age-standardized controls.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Guyatt, G., Mitchell, A., Irvine, E. J., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96, 804–810. PubMed
Irvine, E. J., Feagan, B., Rochon, J., et al. (1994). Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology, 106, 287–296. PubMed
Irvine, E. J. (1996). Quality of life in inflammatory bowel disease and other chronic diseases. Scandinavian Journal of Gastroenterology, 31(Suppl), 26–28. CrossRef
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118, 622–629. PubMed
Aromaa, A., & Koskinen, S. (2004). Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Publications of National Public Health Institute, Series B 12/2004:171.
Sintonen, H. (1994). The 15D- measure of health- related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. National Centre for Health Program Evaluation, working paper 41, Melbourne 1994. ( http://www.buseco.monash.edu.au/centres/che/pubs/wp41.pdf).
Pallis, A. G., Mouzas, I. A., & Vlachonikolis, I. G. (2004). The inflammatory bowel disease questionnaire: A review of its national validation studies. Inflammatory Bowel Disease, 10, 261–269. CrossRef
Ren, W. H., Lai, M., & Chen, Y. (2007). Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn’s disease. Inflammatory Bowel Disease, 13, 903–910. CrossRef
Ghosh, S., & Mitchell, R. (2007). Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. Journal of Crohn’s and Colitis, 1, 10–20. CrossRef
Marquis, P., Marrel, A., & Jambon, B. (2003). Quality of life in patients with stomas: the Montreux Study. Ostomy/Wound Management, 49, 48–55. PubMed
Camilleri-Brennan, J., & Steele, R. J. C. (2001). Objective assessment of quality of life following panproctocolectomy and ileostomy for ulcerative colitis. Annals of the Royal College of Surgeons of England, 83, 321–324. PubMed
Lix, L. M., Graff, L. A., Walker, J. R., et al. (2008). Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Disease, 14, 1575–1584. CrossRef
Irvine, E. J. (2004). Review article: patients’ fears and unmet needs in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 20(Suppl. 4), 54–59. CrossRef
- Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument
Risto P. Roine
Martti A. Färkkilä
Perttu E. T. Arkkila
- Springer Netherlands